skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Elsevier ClinicalKey Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Acute myeloid leukaemia
Acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute myeloid leukaemia

DiNardo, Courtney D ; Erba, Harry P ; Freeman, Sylvie D ; Wei, Andrew H

The Lancet (British edition), 2023-06, Vol.401 (10393), p.2073-2086 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
12
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis

Egan, Grace ; Schimmer, Aaron D.

Trends in cell biology, 2023-06, Vol.33 (6), p.455-462 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
13
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group

Chanswangphuwana, Chantiya ; Polprasert, Chantana ; Owattanapanich, Weerapat ; Kungwankiattichai, Smith ; Tantiworawit, Adisak ; Rattanathammethee, Thanawat ; Limvorapitak, Wasithep ; Saengboon, Supawee ; Niparuck, Pimjai ; Puavilai, Teeraya ; Julamanee, Jakrawadee ; Saelue, Pirun ; Wanitpongpun, Chinadol ; Nakhakes, Chajchawan ; Prayongratana, Kannadit ; Sriswasdi, Chantrapa

Clinical lymphoma, myeloma and leukemia, 2022-12, Vol.22 (12), p.e1075-e1083 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
14
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors

Largeaud, Laetitia ; Bérard, Emilie ; Bertoli, Sarah ; Dufrechou, Stéphanie ; Prade, Naïs ; Gadaud, Noémie ; Tavitian, Suzanne ; Bories, Pierre ; Luquet, Isabelle ; Sarry, Audrey ; De Mas, Véronique ; Huguet, Françoise ; Delabesse, Eric ; Récher, Christian

Leukemia research, 2019-06, Vol.81, p.82-87 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
15
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

Kantarjian, Hagop M ; Roboz, Gail J ; Kropf, Patricia L ; Yee, Karen W L ; O'Connell, Casey L ; Tibes, Raoul ; Walsh, Katherine J ; Podoltsev, Nikolai A ; Griffiths, Elizabeth A ; Jabbour, Elias ; Garcia-Manero, Guillermo ; Rizzieri, David ; Stock, Wendy ; Savona, Michael R ; Rosenblat, Todd L ; Berdeja, Jesus G ; Ravandi, Farhad ; Rock, Edwin P ; Hao, Yong ; Azab, Mohammad ; Issa, Jean-Pierre J

The lancet oncology, 2017-10, Vol.18 (10), p.1317-1326 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
16
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Perl, Alexander E, MD ; Altman, Jessica K, MD ; Cortes, Jorge, MD ; Smith, Catherine, MD ; Litzow, Mark, MD ; Baer, Maria R, MD ; Claxton, David, Prof ; Erba, Harry P, Prof ; Gill, Stan, PhD ; Goldberg, Stuart, MD ; Jurcic, Joseph G, Prof ; Larson, Richard A, Prof ; Liu, Chaofeng, PhD ; Ritchie, Ellen, MD ; Schiller, Gary, MD ; Spira, Alexander I, MD ; Strickland, Stephen A, MD ; Tibes, Raoul, MD ; Ustun, Celalettin, MD ; Wang, Eunice S, Prof ; Stuart, Robert, Prof ; Röllig, Christoph, MD ; Neubauer, Andreas, Prof ; Martinelli, Giovanni, Prof ; Bahceci, Erkut, MD ; Levis, Mark, Dr

The lancet oncology, 2017-08, Vol.18 (8), p.1061-1075 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
17
CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy
CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy
Material Type:
Artigo 		Adicionar ao Meu Espaço

CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy

Shang, Jin ; Chen, Wei-Min ; Liu, Shan ; Wang, Zhi-Hong ; Wei, Tian-Nan ; Chen, Zhi-Zhong ; Wu, Wen-Bing

Leukemia research, 2019-10, Vol.85, p.106198-106198, Article 106198 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
18
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial

DiNardo, Courtney D ; Schuh, Andre C ; Stein, Eytan M ; Montesinos, Pau ; Wei, Andrew H ; de Botton, Stéphane ; Zeidan, Amer M ; Fathi, Amir T ; Kantarjian, Hagop M ; Bennett, John M ; Frattini, Mark G ; Martin-Regueira, Patricia ; Lersch, Frederik ; Gong, Jing ; Hasan, Maroof ; Vyas, Paresh ; Döhner, Hartmut

The lancet oncology, 2021-11, Vol.22 (11), p.1597-1608 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
19
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

Rubnitz, Jeffrey E, Prof ; Inaba, Hiroto, MD ; Dahl, Gary, Prof ; Ribeiro, Raul C, Prof ; Bowman, W Paul, Prof ; Taub, Jeffrey, MD ; Pounds, Stanley, PhD ; Razzouk, Bassem I, MD ; Lacayo, Norman J, MD ; Cao, Xueyuan, PhD ; Meshinchi, Soheil, MD ; Degar, Barbara, MD ; Airewele, Gladstone, MD ; Raimondi, Susana C, Prof ; Onciu, Mihaela, MD ; Coustan-Smith, Elaine, MS ; Downing, James R, Prof ; Leung, Wing, Prof ; Pui, Ching-Hon, Prof ; Campana, Dario, Prof

The lancet oncology, 2010-06, Vol.11 (6), p.543-552 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
20
When the good go bad: Mutant NPM1 in acute myeloid leukemia
When the good go bad: Mutant NPM1 in acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

When the good go bad: Mutant NPM1 in acute myeloid leukemia

Kunchala, Preethi ; Kuravi, Sudhakiranmayi ; Jensen, Roy ; McGuirk, Joseph ; Balusu, Ramesh

Blood reviews, 2018-05, Vol.32 (3), p.167-183 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (6.002)

Data de Publicação 

De até
Refinar
  1. Antes de1973  (52)
  2. 1973Até1984  (321)
  3. 1985Até1996  (1.086)
  4. 1997Até2009  (1.730)
  5. Após 2009  (4.042)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (7.226)
  2. Japonês  (538)
  3. Português  (17)
  4. Espanhol  (2)
  5. Francês  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.